Here’s Hinde Group’s Investment Thesis for Becton, Dickinson and Company (BDX)

5 days ago 5

Soumya Eswaran

Mon, November 17, 2025 astatine 8:23 AM CST 4 min read

Hinde Group, an concern absorption company, has released its third-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The money returned 14.37% (gross) and 13.93% (net) compared to 8.12% for the S&P 500 Total Return. The YTD instrumentality was 36.44% (gross) and 34.91% (Net) compared to 14.83% for the Index. The generative AI concern roar is simply a cardinal crushed the system remains stable, and the banal marketplace is optimistic contempt ongoing governmental and economical challenges. You tin cheque the fund’s apical 5 holdings for its champion picks for 2025.

In its third-quarter 2025 capitalist letter, Hinde Group highlighted stocks specified arsenic Becton, Dickinson and Company (NYSE:BDX). Becton, Dickinson and Company (NYSE:BDX) is simply a healthcare institution that develops and manufactures aesculapian supplies, devices, laboratory equipment, and diagnostic products. The one-month instrumentality of Becton, Dickinson and Company (NYSE:BDX) was 1.07%, and its shares mislaid 13.86% of their worth implicit the past 52 weeks. On November 14, 2025, Becton, Dickinson and Company (NYSE:BDX) banal closed astatine $193.04 per share, with a marketplace capitalization of $55.33 billion.

Hinde Group stated the pursuing regarding Becton, Dickinson and Company (NYSE:BDX) successful its 3rd 4th 2025 capitalist letter:

"We initiated a agelong presumption successful Becton, Dickinson and Company (NYSE:BDX) during the quarter. BDX is simply a peculiar concern investment. It is our archetypal caller presumption since 2022.